]>
IRCT20130428013151N2 IRCT 2020-10-28 Khoram-Abad University of Medical Sciences Evaluation of the effect of mucodentol on people with coronavirus Investigating the effect of slow release mucosal drug in mouth " MUCODENTOL" on disease Symptoms in COVID-19 patients. 2020-04-25 anticipated 200 Complete https://irct.ir/trial/49356 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: The quadruple block method is used to assign patients to two groups A (intervention) and group B (control). To do this, first write a list of blocks and assign numbers to them. (AABB (1) - ABAB (2) - ABBA (3) - BBAA (4) - BABA (5) - BAAB (6) Then use the random number table to randomly select numbers between 1 and 6 and finally the assignment list The treatment will be based on a sequence of letters A and B. Excel software rand function was used for randomization. 0 (exploratory trials) COVID-19. Intervention 1: Dental Intervention Group: mucoadhesive slow-release paste mucodentol (carvacrol 3%) produced in Khorraman Pharmaceutical Company located in Khorramabad has been recommended to use it three times a day as well as before going to the bed by participants and put the paste between the upper lip and gums. Intervention 2: Control group: will not take any medicine or placebo. No - There is not a plan to make this available Justification or reason for not sharing IPD is There is no further information
public Behrooz Farzan
Bimarestan street, Shohada Ashayer hospital
Khorramabad Iran (Islamic Republic of) 6813833946 0098 66 33300661 farzan.b@lums.ac.ir Khoram-Abad University of Medical Sciences scientific Behrooz Farzan
Bimarestan street, Shohada Ashayer hospital
Khorramabad Iran (Islamic Republic of) 6813833946 +98 66 3330 0661 publicrelation@lums.ac.ir Khoram-Abad University of Medical Sciences Iran (Islamic Republic of) Age over 18 years old Mental and physical ability to use this drug for three weeks Lack of sensitivity to drugs and similar drugs People are aware of time, place person, are mentally and emotionally normal be able to communicate verbally for telephone interviews Infected to covid-19 18 years 60 years Both Lack of cooperation Do not use the drug regularly Having corona and need to be hospitalized Drug sensitivity Pregnancy and lactation U07.1 COVID-19 Treatment - Drugs Treatment - Drugs Dental Intervention Group: mucoadhesive slow-release paste mucodentol (carvacrol 3%) produced in Khorraman Pharmaceutical Company located in Khorramabad has been recommended to use it three times a day as well as before going to the bed by participants and put the paste between the upper lip and gums. Control group: will not take any medicine or placebo. The symptoms caused by the Covid-19. Timepoint: Three times a day before bed. Method of measurement: In case of home quarantine, since it is advisable for personal protection, people should not leave the house. At the end of the first week, Second and third week, the desired symptoms will be asked and recorded as a telephone interview. In case of hospitalization, patients will be interviewed and examined. Fever. Timepoint: daily. Method of measurement: Thermometer. Respiratory-general symptoms. Timepoint: daily. Method of measurement: yes/no. Khoram-Abad University of Medical Sciences Approved 2020-05-06 Ethics committee of Lorestan University of Medical Sciences Kamalvand Highway - Lorestan University of Medical Sciences Khorramabad Lorestan Iran (Islamic Republic of)